Physician profile
Amanda S Johnson
NPI 1831182294
$3,150.49
in general payments reported to CMS, 2019-2025
16 companies · $591 in 2025
The $591 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,157 · 2021: $137 · 2022: $275 · 2023: $382 · 2024: $610 · 2025: $591.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,583.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,582.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,137.79 | 2019-2025 | Precision 1, Tryptyr, Simbrinza |
| Bausch & Lomb Americas INC. | $434.84 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Novartis Pharmaceuticals Corporation | $362.09 | 2021-2023 | |
| Tarsus Pharmaceuticals, INC. | $215.02 | 2024-2025 | Xdemvy |
| Quidel Corporation | $213.52 | 2019 | |
| Coopervision INC. | $132.66 | 2025 | Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $108.79 | 2019-2025 | Cequa |
| Dompe US, INC. | $108.38 | 2021-2025 | Oxervate |
| Biotissue Holdings INC. | $95.33 | 2024-2025 | |
| Harrow Eye, LLC | $73.67 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $72.40 | 2023-2025 | Tyrvaya |
| Mallinckrodt Hospital Products INC. | $58.22 | 2024 | Acthar |
| Ocular Therapeutix, INC. | $47.43 | 2023-2024 | Dextenza |
| Kala Pharmaceuticals, INC. | $44.63 | 2021-2022 | |
| Abbvie INC. | $24.99 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.